Artia Global Partners LP Astrazeneca PLC Transaction History
Artia Global Partners LP
- $498 Billion
- Q1 2024
A detailed history of Artia Global Partners LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Artia Global Partners LP holds 190,752 shares of AZN stock, worth $14.7 Million. This represents 2.6% of its overall portfolio holdings.
Number of Shares
190,752
Previous 190,752
-0.0%
Holding current value
$14.7 Million
Previous $12.8 Billion
0.59%
% of portfolio
2.6%
Previous 3.74%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,247Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.72 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.78 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.31 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.66 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...